Supplemental material
Report
Hydrogen/deuterium exchange-mass spectrometry analysis of high concentration biotherapeutics: application to phase-separated antibody formulations
Yuwei TianBioproduct Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA;Department of Chemistry, University of Michigan, Ann Arbor, MI, USA
https://orcid.org/0000-0002-7715-9875View further author information
https://orcid.org/0000-0002-7715-9875View further author information, Lihua HuangBioproduct Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USAhttps://orcid.org/0000-0001-6078-188XView further author information
https://orcid.org/0000-0001-6078-188XView further author information, Brandon T. RuotoloDepartment of Chemistry, University of Michigan, Ann Arbor, MI, USAhttps://orcid.org/0000-0002-6084-2328View further author information
https://orcid.org/0000-0002-6084-2328View further author information & Ning WangBioproduct Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USACorrespondence[email protected]
https://orcid.org/0000-0002-5824-1937View further author information
https://orcid.org/0000-0002-5824-1937View further author information